18 Publications
2021
Does race play a role in complications and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasms?
Peseski, Andrew M⋅Saliba, Antoine N⋅Althouse, Sandra K and Sayar, Hamid
Hematology/oncology and stem cell therapy, February 11, 2021. | Journal Article
 
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial.
Ravandi, Farhad⋅Ravandi, F.⋅Ravandi, Farhad⋅Ravandi, Farhad⋅Roboz, G.J.⋅Roboz, Gail J⋅Roboz, Gail J⋅Roboz, Gail J⋅Wei, Andrew H⋅Wei, A.H.⋅Wei, Andrew H⋅Wei, Andrew H⋅Döhner, Hartmut⋅Döhner, H.⋅Döhner, Hartmut⋅Döhner, Hartmut⋅Pocock, Christopher⋅Pocock, C.⋅Pocock, Christopher⋅Pocock, Christopher⋅Selleslag, Dominik⋅Selleslag, Dominik⋅Selleslag, Dominik⋅Selleslag, D.⋅Montesinos, P.⋅Montesinos, Pau⋅Montesinos, Pau⋅Montesinos, Pau⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, H.⋅Sayar, Hamid⋅Musso, Maurizio⋅Musso, Maurizio⋅Musso, M.⋅Musso, Maurizio⋅Figuera-Alvarez, Angela⋅Figuera-Alvarez, Angela⋅Figuera-Alvarez, A.⋅Figuera-Alvarez, Angela⋅Safah, H.⋅Safah, Hana⋅Safah, Hana⋅Safah, Hana⋅Tse, William⋅Tse, William⋅Tse, W.⋅Tse, William⋅Sohn, Sang K⋅Sohn, Sang Kyun⋅Sohn, Sang Kyun⋅Sohn, S.K.⋅Hiwase, Devendra⋅Hiwase, Devendra⋅Hiwase, Devendra⋅Hiwase, D.⋅Chevassut, T.⋅Chevassut, Timothy⋅Chevassut, Timothy⋅Chevassut, Timothy⋅Pierdomenico, F.⋅Pierdomenico, Francesca⋅Pierdomenico, Francesca⋅Pierdomenico, Francesca⋅La Torre, Ignazia⋅La Torre, I.⋅La Torre, Ignazia⋅Skikne, B.⋅Skikne, Barry⋅Skikne, Barry⋅Skikne, Barry⋅Bailey, Rochelle⋅Bailey, Rochelle⋅Bailey, R.⋅Bailey, Rochelle⋅Zhong, J.⋅Zhong, Jianhua⋅Zhong, Jianhua⋅Zhong, Jianhua⋅Beach, C.L.⋅Beach, C L⋅Beach, C L⋅Beach, C L⋅Dombret, Herve⋅Dombret, H.⋅Dombret, Herve and Dombret, Herve
Journal of hematology & oncology, vol. 14, (no. 1), pp. 133, August 28, 2021. | Journal Article
2019
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study.
Garcia Manero, Guillermo⋅Garcia-Manero, Guillermo⋅Garcia-Manero, Guillermo⋅Garcia-Manero, Guillermo⋅Garcia-Manero, Guillermo⋅Abaza, Yasmin⋅Abaza, Yasmin⋅Abaza, Yasmin⋅Abaza, Yasmin⋅Abaza, Yasmin⋅Takahashi, Koichi⋅Takahashi, Koichi⋅Takahashi, Koichi⋅Takahashi, Koichi⋅Takahashi, Koichi⋅Medeiros, Bruno C.⋅Medeiros, Bruno C⋅Medeiros, Bruno C⋅Medeiros, Bruno C⋅Medeiros, Bruno C⋅Arellano, Martha⋅Arellano, Martha⋅Arellano, Martha⋅Arellano, Martha⋅Arellano, Martha⋅Khaled, Samer K⋅Khaled, Samer K⋅Khaled, Samer K⋅Khaled, Samer K.⋅Khaled, Samer K⋅Patnaik, Mrinal⋅Patnaik, Mrinal⋅Patnaik, Mrinal⋅Patnaik, Mrinal⋅Patnaik, Mrinal⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Tummala, Mohan⋅Tummala, Mohan⋅Tummala, Mohan⋅Tummala, Mohan⋅Tummala, Mohan⋅Patel, Prapti⋅al.⋅Patel, Prapti⋅Patel, Prapti⋅Patel, Prapti⋅Maness-Harris, Lori⋅Maness-Harris, Lori⋅Maness-Harris, Lori⋅Maness-Harris, Lori⋅Stuart, Robert⋅Stuart, Robert⋅Stuart, Robert⋅Stuart, Robert⋅Traer, Elie⋅Traer, Elie⋅Traer, Elie⋅Traer, Elie⋅Karamlou, Kasra⋅Karamlou, Kasra⋅Karamlou, Kasra⋅Karamlou, Kasra⋅Yacoub, Abdulraheem⋅Yacoub, Abdulraheem⋅Yacoub, Abdulraheem⋅Yacoub, Abdulraheem⋅Ghalie, Richard⋅Ghalie, Richard⋅Ghalie, Richard⋅Ghalie, Richard⋅Giorgino, Ruben⋅Giorgino, Ruben⋅Giorgino, Ruben⋅Giorgino, Ruben⋅Atallah, Ehab⋅Atallah, Ehab⋅Atallah, Ehab and Atallah, Ehab
Blood advances, vol. 3, (no. 4), pp. 508-518, February 26, 2019. | Journal Article
2018
Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia.
Ravandi, Farhad⋅Ravandi, Farhad⋅Ravandi, Farhad⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Lancet, Jeffrey E⋅Lancet, Jeffrey E⋅Lancet, Jeffrey E⋅Craig, Michael D⋅Craig, Michael D⋅Craig, Michael D⋅Vey, Norbert⋅Vey, Norbert⋅Vey, Norbert⋅Strickland, Stephen A⋅Strickland, Stephen A⋅Strickland, Stephen A⋅Schiller, Gary J⋅Schiller, Gary J⋅Schiller, Gary J⋅Jabbour, Elias⋅Jabbour, Elias⋅Jabbour, Elias⋅Pigneux, Arnaud⋅Pigneux, Arnaud⋅Pigneux, Arnaud⋅Horst, Heinz-August⋅Horst, Heinz-August⋅Horst, Heinz-August⋅Récher, Christian⋅Récher, Christian⋅Récher, Christian⋅Klimek, Virginia M⋅Klimek, Virginia M⋅Klimek, Virginia M⋅Cortes, Jorge E⋅Cortes, Jorge E⋅Cortes, Jorge E⋅Carella, Angelo-Michele⋅Carella, Angelo-Michele⋅Carella, Angelo-Michele⋅Egyed, Miklos⋅Egyed, Miklos⋅Egyed, Miklos⋅Krug, Utz⋅Krug, Utz⋅Krug, Utz⋅Fox, Judith A⋅Fox, Judith A⋅Fox, Judith A⋅Craig, Adam R⋅Craig, Adam R⋅Craig, Adam R⋅Ward, Renee⋅Ward, Renee⋅Ward, Renee⋅Smith, Jennifer A⋅Smith, Jennifer A⋅Smith, Jennifer A⋅Acton, Gary⋅Acton, Gary⋅Acton, Gary⋅Kantarjian, Hagop M⋅Kantarjian, Hagop M⋅Kantarjian, Hagop M⋅Stuart, Robert K⋅Stuart, Robert K and Stuart, Robert K
Haematologica, vol. 103, (no. 11), pp. e514-e518, November 2018. | Journal Article
2017
Therapies for acute myeloid leukemia: vosaroxin.
Sayar, Hamid and Bashardoust, Parvaneh
OncoTargets and therapy, vol. 10, pp. 3957-3963, 2017. | Journal Article
2016
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia.
Roboz, G.J.⋅Roboz, Gail J⋅Roboz, Gail J⋅Montesinos, Pau⋅Montesinos, P.⋅Montesinos, Pau⋅Selleslag, D.⋅Selleslag, Dominik⋅Selleslag, Dominik⋅Wei, Andrew⋅Wei, A.⋅Wei, Andrew⋅Jang, J.-H.⋅Jang, Jun-Ho⋅Jang, Jun-Ho⋅Falantes, Jose⋅Falantes, Jose⋅Falantes, J.⋅Voso, Maria T⋅Voso, M.T.⋅Voso, Maria T⋅Sayar, Hamid⋅Sayar, H.⋅Sayar, Hamid⋅Porkka, Kimmo⋅Porkka, K.⋅Porkka, Kimmo⋅Marlton, P.⋅Marlton, Paula⋅Marlton, Paula⋅Almeida, Antonio⋅Almeida, A.⋅Almeida, Antonio⋅Mohan, Sanjay⋅Mohan, Sanjay⋅Mohan, S.⋅Ravandi, F.⋅Ravandi, Farhad⋅Ravandi, Farhad⋅Garcia-Manero, Guillermo⋅Garcia-Manero, G.⋅Garcia Manero, Guillermo⋅Skikne, B.⋅Skikne, Barry⋅Skikne, Barry⋅Kantarjian, H.⋅Kantarjian, Hagop and Kantarjian, Hagop
Future oncology (London, England), vol. 12, (no. 3), pp. 293-302, February 2016. | Journal Article
2015
Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia.
Khawaja, Muhammad Rizwan⋅Perkins, Susan M⋅Schwartz, Jennifer E⋅Robertson, Michael J⋅Kiel, Patrick J⋅Sayar, Hamid⋅Cox, Elizabeth A⋅Vance, Gail H⋅Farag, Sherif S⋅Cripe, Larry D and Nelson, Robert P
American journal of hematology, vol. 90, (no. 2), pp. 97-99, February 2015. | Journal Article
 
Pilot study of erlotinib in patients with acute myeloid leukemia.
Sayar, Hamid⋅Sayar, Hamid⋅Czader, Magdalena⋅Czader, Magdalena⋅Amin, Chirag⋅Amin, Chirag⋅Cangany, Mary⋅Cangany, Mary⋅Konig, Heiko⋅Konig, Heiko⋅Cripe, Larry and Cripe, Larry D
Leukemia research, vol. 39, (no. 2), pp. 170-172, February 2015. | Journal Article
 
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
Ravandi, Farhad⋅Ravandi, Farhad⋅Ravandi, F.⋅Ravandi, Farhad⋅Ravandi, Farhad⋅Ravandi, Farhad⋅Ravandi, Farhad⋅Ravandi, Farhad⋅Ritchie, Ellen K⋅Ritchie, Ellen⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Ritchie, Ellen K⋅Ritchie, E.K.⋅Ritchie, Ellen K⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, H.⋅Sayar, Hamid⋅Lancet, Jeffrey⋅Lancet, Jeffrey E⋅Lancet, J.E.⋅Lancet, Jeffrey E⋅Lancet, Jeffrey E⋅Lancet, Jeffrey E⋅Lancet, Jeffrey E⋅Lancet, Jeffrey E⋅Craig, Michael D⋅Craig, Michael⋅Craig, Michael D⋅Craig, Michael D⋅Craig, Michael D⋅Craig, M.D.⋅Craig, Michael D⋅Craig, Michael D⋅Vey, Norbert⋅Vey, Norbert⋅Vey, N.⋅Vey, Norbert⋅Vey, Norbert⋅Vey, Norbert⋅Vey, Norbert⋅Vey, Norbert⋅Strickland, Stephen A⋅Strickland, Stephen A⋅Strickland, S.A.⋅Strickland, Stephen A⋅Strickland, Stephen A⋅Strickland, Stephen⋅Strickland, Stephen A⋅Strickland, Stephen A⋅Schiller, Gary J⋅Schiller, Gary J⋅Schiller, Gary J⋅Schiller, Gary J⋅Schiller, Gary J⋅Schiller, Gary J⋅Schiller, Gary⋅Schiller, G.J.⋅Jabbour, Elias⋅Jabbour, Elias⋅Jabbour, E.⋅Jabbour, Elias⋅Jabbour, Elias⋅Jabbour, Elias⋅Jabbour, Elias⋅Jabbour, Elias⋅Erba, Harry P⋅Erba, Harry P⋅Erba, Harry P⋅Erba, Harry P⋅Erba, Harry P⋅Erba, Harry P⋅Erba, H.P.⋅Erba, Harry⋅Pigneux, Arnaud⋅Pigneux, A.⋅Pigneux, Arnaud⋅Pigneux, Arnaud⋅Pigneux, Arnaud⋅Pigneux, Arnaud⋅Pigneux, Arnaud⋅Pigneux, Arnaud⋅Horst, Heinz-August⋅Horst, Heinz-August⋅Horst, Heinz-August⋅Horst, Heinz-August⋅Horst, Heinz-August⋅Horst, Heinz-August⋅Horst, H.-A.⋅Horst, Heinz-August⋅Recher, Christian⋅Recher, C.⋅Recher, Christian⋅Recher, Christian⋅Recher, Christian⋅Recher, Christian⋅Recher, Christian⋅Recher, Christian⋅Klimek, Virginia M⋅Klimek, Virginia M⋅Klimek, Virginia M⋅Klimek, Virginia M⋅Klimek, V.M.⋅Klimek, Virginia M⋅Klimek, Virginia M⋅Klimek, Virginia⋅Cortes, Jorge⋅Cortes, Jorge⋅Cortes, Jorge⋅Cortes, J.⋅Cortes, Jorge⋅Cortes, Jorge⋅Cortes, Jorge⋅Cortes, Jorge⋅Roboz, Gail J⋅Roboz, Gail J⋅Roboz, Gail J⋅Roboz, Gail J⋅Roboz, G.J.⋅Roboz, Gail J⋅Roboz, Gail⋅Roboz, Gail J⋅Odenike, O.⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Odenike, Olatoyosi⋅Thomas, X.⋅Thomas, Xavier⋅Thomas, Xavier⋅Thomas, Xavier⋅Thomas, Xavier⋅Thomas, Xavier⋅Thomas, Xavier⋅Thomas, Xavier⋅Havelange, Violaine⋅Havelange, Violaine⋅Havelange, Violaine⋅Havelange, Violaine⋅Havelange, Violaine⋅Havelange, Violaine⋅Havelange, V.⋅Havelange, Violaine⋅Maertens, Johan⋅Maertens, Johan⋅Maertens, Johan⋅Maertens, Johan⋅Maertens, Johan⋅Maertens, Johan⋅Maertens, J.⋅Maertens, Johan⋅Derigs, Hans-Günter⋅Derigs, Hans-Günter⋅Derigs, Hans-Günter⋅Derigs, H.-G.⋅Derigs, Hans-Günter⋅Derigs, Hans-Günter⋅Derigs, Hans-Günter⋅Derigs, Hans-Günter⋅Heuser, Michael⋅Heuser, Michael⋅Heuser, M.⋅Heuser, Michael⋅Heuser, Michael⋅Heuser, Michael⋅Heuser, Michael⋅Heuser, Michael⋅Damon, Lloyd⋅Damon, L.⋅Damon, Lloyd⋅Damon, Lloyd⋅Damon, Lloyd⋅Damon, Lloyd⋅Damon, Lloyd⋅Damon, Lloyd⋅Powell, Bayard⋅Powell, Bayard L⋅Powell, Bayard L⋅Powell, Bayard L⋅Powell, Bayard L⋅Powell, Bayard L⋅Powell, Bayard L⋅Powell, B.L.⋅Gaidano, G.⋅Gaidano, Gianluca⋅Gaidano, Gianluca⋅Gaidano, Gianluca⋅Gaidano, Gianluca⋅Gaidano, Gianluca⋅Gaidano, Gianluca⋅Gaidano, Gianluca⋅Carella, Angelo-Michele⋅Carella, Angelo-Michele⋅Carella, Angelo-Michele⋅Carella, A.-M.⋅Carella, Angelo-Michele⋅Carella, Angelo-Michele⋅Carella, Angelo-Michele⋅Carella, Angelo-Michele⋅Wei, Andrew⋅Wei, Andrew⋅Wei, Andrew⋅Wei, Andrew⋅Wei, Andrew⋅Wei, A.⋅Wei, Andrew⋅Wei, Andrew⋅Hogge, Donna⋅Hogge, Donna⋅Hogge, Donna⋅Hogge, D.⋅Hogge, Donna⋅Hogge, Donna⋅Hogge, Donna⋅Hogge, Donna⋅Craig, Adam R⋅Craig, Adam R⋅Craig, Adam R⋅Craig, A.R.⋅Craig, Adam R⋅Craig, Adam R⋅Craig, Adam R⋅Craig, Adam⋅Fox, Judith A⋅Fox, Judith A⋅Fox, Judith A⋅Fox, Judith A⋅Fox, Judith A⋅Fox, Judith A⋅Fox, Judith⋅Fox, J.A.⋅Ward, Renee⋅Ward, Renee⋅Ward, Renee⋅Ward, Renee⋅Ward, Renee⋅Ward, Renee⋅Ward, Renee⋅Ward, R.⋅Smith, Jennifer A⋅Smith, Jennifer A⋅Smith, Jennifer A⋅Smith, Jennifer A⋅Smith, J.A.⋅Smith, Jennifer A⋅Smith, Jennifer⋅Smith, Jennifer A⋅Acton, Gary⋅Acton, Gary⋅Acton, Gary⋅Acton, Gary⋅Acton, Gary⋅Acton, Gary⋅Acton, Gary⋅Acton, G.⋅Mehta, Cyrus⋅Mehta, Cyrus⋅Mehta, Cyrus⋅Mehta, Cyrus⋅Mehta, Cyrus⋅Mehta, Cyrus⋅Mehta, Cyrus⋅Mehta, C.⋅Stuart, Robert K⋅Stuart, Robert K⋅Stuart, R.K.⋅Stuart, Robert⋅Stuart, Robert K⋅Stuart, Robert K⋅Stuart, Robert K⋅Stuart, Robert K⋅Kantarjian, Hagop M⋅Kantarjian, Hagop⋅Kantarjian, Hagop M⋅Kantarjian, Hagop M⋅Kantarjian, Hagop M⋅Kantarjian, Hagop M⋅Kantarjian, H.M. and Kantarjian, Hagop M
The Lancet. Oncology, vol. 16, (no. 9), pp. 1025-1036, September 2015. | Journal Article
2013
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)
Erba, Harry P⋅Erba, Harry⋅Erba, Harry P⋅Erba, Harry⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Sayar, Hamid⋅Juckett, Mark⋅Juckett, Mark⋅Juckett, Mark⋅Juckett, Mark⋅Lahn, Michael⋅Lahn, Michael⋅Lahn, Michael⋅Lahn, Michael⋅Andre, Valerie⋅Callies, Sophie⋅Schmidt, Shelly⋅Kadam, Sunil⋅Brandt, John⋅Van Bockstaele, Dirk and Andreeff, Michael
Investigational New Drugs, vol. 31, (no. 4), pp. 1023-34, Aug 2013. | Journal Article
2012
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam, Rajasubramaniam⋅Gade, Padmaja⋅Wilson-Weekes, Annique⋅Sayar, Hamid⋅Suvannasankha, Attaya⋅Goswami, Chirayu⋅Li, Lang⋅Gupta, Sushil⋅Cardoso, Angelo A⋅Al Baghdadi, Tareq⋅Sargent, Katie J⋅Cripe, Larry D⋅Kalvakolanu, Dhananjaya V and Boswell, H S
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 18, (no. 2), pp. 360-9, 2012/Jan/15. | Journal Article
2011
Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy.
Sayar, Hamid⋅Sharfuddin, Asif A⋅Taber, Tim and Mehta, Rakesh
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, vol. 9, (no. 5), pp. 336-9, 2011/Oct. | Journal Article
 
Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: a study of the Hoosier Oncology Group.
Sayar, Hamid⋅Chan, Rebecca⋅Orschell, Christie M⋅Chan, Edward M⋅Yu, Zhangsheng⋅Hood, Daniel⋅Plett, Artur⋅Yang, Zhenyun⋅Hui, Chua L⋅Nabinger, Sarah C⋅Kohlbacher, Kristopher J⋅West, Evan S⋅Walter, Amanda⋅Sampson, Carol⋅Wu, Jingwei and Cripe, Larry D
Leukemia research, vol. 35, (no. 8), pp. 1108-10, 2011/Aug. | Journal Article
2010
Tumor MET expression may not predict the risk of venous thromboembolism in cancer patients.
Sayar, Hamid⋅Bunning, Jeffrey T⋅Bocklage, Thèrése⋅Lee, Sang-Joon⋅Libby, Edward and Rabinowitz, Ian
Oncology research, vol. 19, (no. 2), pp. 93-7, 2010. | Journal Article
2009
Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies.
Sayar, Hamid⋅Shen, Z⋅Lee, S J⋅Royce, Melanie E⋅Rabinowitz, Ian⋅Lee, F⋅Smith, H⋅Eberhardt, S⋅Maestas, A⋅Lu, H and Verschraegen, Claire
Investigational new drugs, vol. 27, (no. 2), pp. 153-8, 2009/Apr. | Journal Article
2006
Fragmentation hemolytic anemia 8 years after replacement of ascending aorta with a sutureless intraluminal graft.
Sayar, Hamid⋅Dietl, Charles A⋅Helms, Andrew and Rabinowitz, Ian
American journal of hematology, vol. 81, (no. 3), pp. 175-7, 2006/Mar. | Journal Article
2005
Malignant adnexal masses in pregnancy.
Sayar, Hamid⋅Lhomme, Catherine and Verschraegen, Claire
Obstetrics and gynecology clinics of North America, vol. 32, (no. 4), pp. 569-93, 2005/Dec. | Journal Article
2004
Where west meets east: the complex mtDNA landscape of the southwest and Central Asian corridor.
Quintana-Murci, Lluis⋅Chaix, Raphaëlle⋅Wells, R S⋅Behar, Doron M⋅Sayar, Hamid⋅Scozzari, Rosaria⋅Rengo, Chiara⋅Al-Zahery, Nadia⋅Semino, Ornella⋅Santachiara-Benerecetti, A S⋅Coppa, Alfredo⋅Ayub, Qasim⋅Mohyuddin, Aisha⋅Tyler-Smith, Chris⋅Qasim Mehdi, S⋅Torroni, Antonio and McElreavey, Ken
American journal of human genetics, vol. 74, (no. 5), pp. 827-45, 2004/May. | Journal Article